The top 10 generic drug makers by 2021 revenue

After a period of stagnant sales largely because of increased competition and pricing pressures, the generic drug industry took another hit during the coronavirus pandemic.   In its 10-K annual report to the Securities and Exchange Commission, generics giant Teva described how the pandemic impacted sales of its copycat drugs. The company noted that "supply discontinuities due to regulatory actions, labor disturbances and approval delays" all affected its overall performance. The drugmaker likely wasn't alone. | Many producers of generic drugs have struggled to achieve growth in recent years due to pricing pressures. But there are promising signs that the industry is ready for an uptick, and they were evident in 2021 as eight of the top 10 companies by generics sales realized growth.

Top five generic drug makers

13 of top 20 biopharma companies by revenue report over 10 per cent YoY revenue growth from 2020 to 2021: GlobalData - Express Pharma

Research and Development in the Pharmaceutical Industry

TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022

The Top 10 Pharma Companies by Revenue

Generic drugs Market Size, Share & Trends 2027

Report reveals how pharmaceutical companies manipulate the prescription drug market to raise prices

Which is the leading pharmaceutical company in the world? - Quora

Top Drugs & Pharma Companies of 2018 by Revenues

The top 10 generic drug makers by 2021 revenue